Clinical study on the correlation between metabolic syndrome and colorectal carcinoma

ANZ Journal of Surgery

Volumn 80, Issue 5, 2010, Pages 331-336

  Shen, Zhanlong ^a   Wang, Shan ^a   Ye, Yingjiang ^a   Yin, Mujun ^a   Yang, Xiaodong ^a   Jiang, Kewei ^a   Liu, Yan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Blood lipid obesity; Body mass index; Clinicopathologic parameter; Colonic carcinoma; Insulin resistance; Liver metastases; Metabolic syndrome; Rectal carcinoma; Recurrence; Survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; COLON TUMOR; FEMALE; HUMAN; INCIDENCE; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; RECTUM TUMOR; RISK FACTOR; SURVIVAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; COLONIC NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RECTAL NEOPLASMS; RISK FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77952196864     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2009.05084.x     Document Type: Article

References (21)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
2. Albanes D. Energy balance, body size, and cancer. Crit. Rev. Oncol. Hematol. 1990 10 : 283 303.
3. Russo A, Franceschi S, La Vecchia C et al. Body size and colorectal-cancer risk. Int. J. Cancer 1998 78 : 161 165.
4. Kono S, Handa K, Hayabuchi H et al. Obesity, weight gain and risk of colon adenomas in Japanese men. Jpn. J. Cancer Res. 1999 90 : 805 811.
5. Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH. Splanchnic insulin metabolism in obesity. Infuence of body fat distribution. J. Clin. Invest. 1986 78 : 1648 1657.
6. Gupta K, Krishnaswamy G, Karnad A, Peiris AN. Insulin: a novel factor in carcinogenesis. Am. J. Med. Sci. 2002 323 : 140 145.
7. Bjork J, Nilsson J, Hultcrantz R, Johansson C. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line eIEC-6 and the colon cancer cell line HT 29. Scand. J. Gastroenterol. 1993 28 : 879 884.
8. Wu X, Fan Z, Masui H, Rosen N, Mendelsohn J. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J. Clin. Invest. 1995 95 : 1897 1905.
9. Koenuma M, Yamori T, Tsuruo T. Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants for colon carcinoma 26. Jpn. J. Cancer Res. 1989 80 : 51 8.
10. Chang CK, Ulrich CM. Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients. Diabetologia 2003 46 : 595 607.
11. Beck-Nielsen H, Hother-Nielsen O. Obesity in type 2 diabetes mellitus. In : LeRoith D, Taylor SI, Olefsky JM (eds). Diabetes Mellitus.
12. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 37 : 1595 1607.
13. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol. Biomarks Prev. 1996 5 : 1013 1015.
14. Ma J, Giovannucci E, Pollak M et al. A prospective study of plasma C-peptide and colorectal cancer risk in men. J. Natl. Cancer Inst. 2004 96 : 546 553. (Pubitemid 38559579)
15. Trevisan M, Liu J, Muti P et al. Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol. Biomarkers Prev. 2001 10 : 937 941.
16. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol. Biomarkers Prev. 2002 11 : 385 391.
17. Ahmed R L, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006 107 : 28 36.
18. Chiu HM, Lin JT, Shun CT et al. Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin. Gastroenterol. Hepatol. 2007 5 : 221 229.
19. Pasanisi P, Berrino F, Petris MD, Venturelli E, Mastroianni A, Panico S. Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int. J. Cancer 2006 119 : 236 238.
20. Nam SY, Marcus C. Growth hormone and adipocyte function in obesity. Hormone. Res. 2000 53 : 87 97.
21. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 2000 92 : 1472 1489.